501 results on '"DONADIEU, Jean"'
Search Results
2. Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms
3. Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition
4. A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome
5. Childhood Langerhans cell histiocytosis hematological involvement: severity associated with BRAFV600E loads
6. Lineage switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis
7. Stem Cell Transplantation in Patients Affected by Shwachman-Diamond Syndrome: Expert Consensus and Recommendations From the EBMT Severe Aplastic Anaemia Working Party
8. Heterozygous variants of CLPB are a cause of severe congenital neutropenia
9. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
10. Establishment of MOS-SF36 percentile ranks in the general youth French population
11. Publisher Correction: Somatic genetic rescue of a germline ribosome assembly defect
12. CXCR4 signaling controls dendritic cell location and activation at steady state and in inflammation
13. High frequency of clonal hematopoiesis in Erdheim-Chester disease
14. Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort
15. Somatic genetic rescue of a germline ribosome assembly defect
16. EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome
17. Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition
18. Validation of Liquid Chromatography Coupled with Tandem Mass Spectrometry for the Determination of 12 Tyrosine Kinase Inhibitors (TKIs) and Their Application to Therapeutic Drug Monitoring in Adult and Pediatric Populations
19. Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond–like syndrome
20. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease
21. P1058: CHILDHOOD-ONSET ERDHEIM-CHESTER DISEASE IN THE MOLECULAR ERA: CLINICAL PHENOTYPE AND LONG-TERM OUTCOME OF 21 PATIENTS
22. How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome
23. Childhood Langerhans cell histiocytosis with severe lung involvement: a nationwide cohort study
24. Childhood-onset Erdheim-Chester Disease in the molecular era: clinical phenotype and long-term outcome of 21 patients
25. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
26. Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type
27. Validation of Liquid Chromatography Coupled with Tandem Mass Spectrometry for the Determination of 12 Tyrosine Kinase Inhibitors (TKIs) and Their Application to Therapeutic Drug Monitoring in Adult and Pediatric Populations.
28. Somatic genetic alterations predict hematological progression in GATA2 deficiency
29. Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation
30. Severe chronic primary neutropenia in adults: report on a series of 108 patients
31. Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study
32. Molecular and clinicopathologic characterization of pediatric histiocytoses
33. Genetics of severe congenital neutropenia as a gateway to personalized therapy
34. The international dataset on the association between Langerhans Cell Histiocytosis and other malignancies
35. NT-Probnp and High-Sensitivity Troponin T Fail to Detect Cardiac Involvement in Erdheim-Chester Disease
36. Oral SGLT2 Inhibitors in Glycogen Storage Disease Type Ib and G6PC3-Deficiency. Preliminary Results from an Off-Label Study of 21 Patients
37. The Morphologic Spectrum of Myelokathexis in WHIM Syndrome and Germline CXCR4 Variants: New Insights into Cellular Changes in the Bone Marrow and Peripheral Blood
38. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation
39. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis
40. Hypoalphalipoproteinemia and BRAFV600E Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease
41. Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms
42. Distinctive vasculopathy with systemic involvement due to levamisole long-term therapy: a case report
43. Lineage-switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis
44. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis
45. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation
46. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia
47. Molecular and clinicopathologic characterization of pediatric histiocytoses.
48. ALK-positive histiocytosis:a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
49. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
50. Additional file 3 of Establishment of MOS-SF36 percentile ranks in the general youth French population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.